TradingView
RocketTickers
Dec 17, 2018 5:30 PM

FDA Approves Nplate® (Romiplostim) For Use In Pediatric Patients Long

NASDAQ:AMGN1D
Amgen Inc.NASDAQ

Description

⋅
AMGN: Amgen
2018-12-14 16:00:00
FDA Approves Nplate® (Romiplostim) For Use In Pediatric Patients With Immune Thrombocytopenia
Beyond Technical Analysis
More